AstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'

Key TakeawaysAstraZeneca announced plans Tuesday for a “new era of growth" with 75% revenue growth and 20 new drug launches by 2030.The pharmaceutical company said it is targeting $80 billion in total annual revenue by 2030, up from$45.8 billion in 2023.AstraZeneca ADRs rose to a record high Tuesday following the announcement. AstraZeneca's (AZN) American depositary receipts (ADRs) rose over 2% to a record high Tuesday after the Anglo-Swedish drug maker announced what it called its “bold ambition” for fut ...